Hypoxia--a key regulatory factor in tumour growth

Nature Reviews. Cancer
Adrian L Harris

Abstract

Cells undergo a variety of biological responses when placed in hypoxic conditions, including activation of signalling pathways that regulate proliferation, angiogenesis and death. Cancer cells have adapted these pathways, allowing tumours to survive and even grow under hypoxic conditions, and tumour hypoxia is associated with poor prognosis and resistance to radiation therapy. Many elements of the hypoxia-response pathway are therefore good candidates for therapeutic targeting.

References

Nov 13, 1995·Biochemical and Biophysical Research Communications·G L WangG L Semenza
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·G L WangG L Semenza
May 1, 1997·Nature Medicine·G U DachsA L Harris
Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·P H MaxwellP J Ratcliffe
Aug 1, 1997·Journal of Bioenergetics and Biomembranes·S MazurekE Eigenbrodt
Apr 16, 1998·The Journal of Biological Chemistry·N S LevyA P Levy
May 5, 1998·Molecular and Cellular Biology·C SchmaltzD E Fisher
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·J B HogeneschC A Bradfield
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·S V IvanovM I Lerman
Jan 14, 1999·Genes & Development·S BhattacharyaD M Livingston
Jan 29, 1999·Journal of the National Cancer Institute·C A Thrash-Bingham, K D Tartof
Mar 31, 1999·Trends in Biochemical Sciences·C V Dang, G L Semenza
May 18, 1999·The Journal of Biological Chemistry·S F YanD M Stern
Jul 15, 1999·Biochemical and Biophysical Research Communications·H SeimiyaT Tsuruo
Sep 24, 1999·Biochemical and Biophysical Research Communications·H OkudaT Shuin
Nov 24, 1999·The Journal of Biological Chemistry·P W ConradD E Millhorn
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Feb 19, 2000·Biochemical and Biophysical Research Communications·S W LeeK W Kim
May 24, 2000·The Journal of Biological Chemistry·M E CockmanP H Maxwell
Jun 30, 2000·Biochemical and Biophysical Research Communications·E MaltepeM C Simon
Jul 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·J PengG H Fong
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·R K Bruick
Sep 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·T KamuraJ W Conaway

❮ Previous
Next ❯

Citations

May 11, 2007·Archives of Pharmacal Research·WenYi JinKiHwan Bae
Sep 14, 2010·Cellular and Molecular Life Sciences : CMLS·Wei GuoChuanshu Huang
Dec 21, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·L Eric HuangAdrian L Harris
Apr 13, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Katjana DaskalowThorsten Cramer
Apr 13, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Daniel A Tennant, Eyal Gottlieb
Jun 8, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Houssem BenlalamSalem Chouaib
Nov 1, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Matthias T WyssSimon M Ametamey
Nov 19, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Xiao-Feng LiJoseph A O'Donoghue
Mar 31, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Hyun Hoon ChungSoon-Beom Kang
May 13, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Zhuang Liu, Rui Peng
Jul 10, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Ingrid Dijkgraaf, Otto C Boerman
Sep 15, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Hyun Hoon ChungSoon-Beom Kang
Feb 22, 2012·European Journal of Nuclear Medicine and Molecular Imaging·Kazuhiro KitajimaKazuro Sugimura
May 15, 2013·Cancer Immunology, Immunotherapy : CII·Stefanie TrojandtMatthias Bros
May 17, 2005·Cancer Chemotherapy and Pharmacology·Eva L LundPaul E G Kristjansen
Aug 15, 2006·Cancer Chemotherapy and Pharmacology·Xianhua CaoDuxin Sun
May 16, 2012·Cancer Chemotherapy and Pharmacology·Angela Segler, Apostolia-Maria Tsimberidou
Oct 12, 2012·Cancer Chemotherapy and Pharmacology·Peter M WilsonHeinz-Josef Lenz
Apr 7, 2005·World Journal of Urology·John S LamRobert A Figlin
Dec 20, 2005·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·Jørund SollidGöran E Nilsson
Sep 3, 2010·Pediatric Surgery International·Tetsuya YamagataTakao Ohki
Jul 30, 2005·International Journal of Colorectal Disease·George E TheodoropoulosDimitrios Panoussopoulos
Jul 3, 2008·International Journal of Colorectal Disease·R RajaganeshanD G Jayne
Jun 17, 2009·International Journal of Colorectal Disease·Klaus Jürgen SchmitzKurt Werner Schmid
Jul 12, 2005·Pflügers Archiv : European journal of physiology·Eoin P Cummins, Cormac T Taylor
Dec 12, 2007·Pflügers Archiv : European journal of physiology·Tereza HolotnakovaSilvia Pastorekova
Jan 18, 2006·Journal of Cancer Research and Clinical Oncology·Joo-Young KimInn-Oc Han
Oct 24, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·David R Mole, Peter J Ratcliffe
Aug 5, 2011·Journal of Molecular Modeling·Pandian SokkarMurugesan Ramachandran
Sep 26, 2012·Annals of Biomedical Engineering·Anirikh ChakrabartiJeffrey D Varner
Sep 1, 2005·Apoptosis : an International Journal on Programmed Cell Death·N Hail
Sep 1, 2005·Apoptosis : an International Journal on Programmed Cell Death·C -N LeeF -J Hsieh
Dec 1, 2006·Apoptosis : an International Journal on Programmed Cell Death·Nagathihalli S NagarajWolfgang Zacharias
Jun 12, 2012·Apoptosis : an International Journal on Programmed Cell Death·Hak-Su KimJoohun Ha
Aug 4, 2010·Breast Cancer Research and Treatment·Katie T HuangStephen B Fox
Sep 15, 2012·Breast Cancer Research and Treatment·Veronique M NeumeisterLyndsay Harris
Apr 4, 2007·Cancer Metastasis Reviews·D LukashevM Sitkovsky
Apr 19, 2007·Cancer Metastasis Reviews·Peter Vaupel, Arnulf Mayer
Apr 7, 2007·Cancer Metastasis Reviews·Giovanni Melillo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.